IP Library Granted Patent US 10,272,192
Granted Patent B2
US 10,272,192 · App. 14/621,501 · Granted Apr 30, 2019

Site specific drug delivery device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,272,192
App. No.
14/621,501
Granted
Apr 30, 2019
Kind
B2
Abstract

A drug delivery device is provided for directly treating a treatment site. The device allows body fluids to perfuse past the device while it is expanded to increase the amount of treatment time that is possible. The drug is delivered through a hollow helical tube that extends around a support structure. The hollow tube includes a series of lateral holes to allow the drug to directly reach the desired treatment site.

Claims (23)

1. An intraluminal drug delivery device, comprising:

a shaft adapted to extend from a proximal portion outside an access site into a patient's body to a distal portion within said patient's body;

a cylindrical support structure disposed along said distal portion of said shaft, said support structure being expandable between a compressed configuration and an expanded configuration;

a plurality of connectors attaching a proximal end of said support structure to said shaft, said connectors allowing said support structure to expand away from said shaft, wherein a plurality of openings are disposed between said connectors and between said shaft and said support structure, a bodily fluid thereby being permitted to flow through said openings and past said support structure when said support structure is expanded and wherein a distal end of said support structure is unconnected to said shaft;

at least one hollow tube extending helically around said support structure and being compressible and expandable therewith, said at least one hollow tube comprising a plurality of lateral holes extending through a wall of said at least one hollow tube to provide fluid communication between a lumen extending therethrough and an exterior of said at least one hollow tube; and

a fluid delivery lumen in communication with said lumen of said at least one hollow tube, said fluid delivery lumen extending from said hollow tube to a proximal end adapted to be disposed outside said access site, a therapeutic fluid thereby being deliverable through said fluid delivery lumen and said lumen of said at least one hollow tube and exiting through said holes, wherein said holes extend from said lumen of said at least one hollow tube radially outward.

2. The intraluminal drug delivery device according to claim 1 , wherein said holes do not extend radially inward.

3. The intraluminal drug delivery device according to claim 1 , wherein said support structure is self-expanding, and further comprising a restraining sheath disposed around said support structure and said at least one hollow tube to retain said support structure and said at least one hollow tube in said compressed configuration, said support structure and said at least one hollow tube expanding to said expanded configuration upon withdrawing said restraining sheath from said support structure and said at least one hollow tube.

4. The intraluminal drug delivery device according to claim 1 , wherein said at least one hollow tube is interlaced with a wall of said support structure.

5. The intraluminal drug delivery device according to claim 1 , wherein said support structure comprises filaments having an outer diameter and forming a braided structure of filaments, said at least one hollow tube being braided with said filaments.

6. The intraluminal drug delivery device according to claim 5 , wherein said at least one hollow tube comprises a larger outer diameter than said outer diameter of said filaments forming said braided structure of said filaments.

7. The intraluminal drug delivery device according to claim 1 , wherein said at least one hollow tube is stiffer than filaments comprising said support structure.

8. The intraluminal drug delivery device according to claim 1 , wherein said at least one hollow tube and filaments comprising said support structure are made of metal.

9. The intraluminal drug delivery device according to claim 1 , wherein said at least one hollow tube is a plurality of said hollow tubes, wherein said plurality of said hollow tubes extend around said support structure in only one direction, none of said plurality of said hollow tubes thereby extending around said support structure in an opposite direction.

10. The intraluminal drug delivery device according to claim 1 , wherein said at least one hollow tube is a single tube.

11. The intraluminal drug delivery device according to claim 1 , wherein said fluid delivery lumen extends through said shaft.

12. The intraluminal drug delivery device according to claim 1 , wherein said holes do not extend radially inward, and said at least one hollow tube is interlaced with a wall of said support structure.

13. The intraluminal drug delivery device according to claim 12 , wherein said support structure is self-expanding, and further comprising a restraining sheath disposed around said support structure and said at least one hollow tube to retain said support structure and said at least one hollow tube in said compressed configuration, said support structure and said at least one hollow tube expanding to said expanded configuration upon withdrawing said restraining sheath from said support structure and said at least one hollow tube, and said support structure comprises filaments having an outer diameter and forming a braided structure of said filaments, said at least one hollow tube braided with said filaments.

14. The intraluminal drug delivery device according to claim 13 , wherein said at least one hollow tube comprises a larger outer diameter than said outer diameter of said filaments, and wherein said at least one hollow tube extends around said support structure in only one direction.

15. The intraluminal drug delivery device according to claim 14 , wherein said at least one hollow tube is stiffer than said filaments, said at least one hollow tube and said filaments are made of metal, and said fluid delivery lumen extends through said shaft.

16. The intraluminal drug delivery device according to claim 1 , wherein the at least one hollow tube is a plurality of said tubes wherein said holes do not extend radially inward, and said plurality of said tubes extend around said support structure in only one direction, none of said plurality of said tubes thereby extending around said support structure in an opposite direction.

17. The intraluminal drug delivery device according to claim 16 , wherein said plurality of said tubes are interlaced with a wall of said support structure.

18. The intraluminal drug delivery device according to claim 1 , wherein said support structure comprises a braided structure of filaments, said at least one hollow tube being braided with said filaments and wherein said at least one hollow tube is a single tube.

Assignments (5)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2015
From: CAMPBELL, TRIONA
To: COOK IRELAND LIMITED
Reel/Frame 036780/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2015
From: COOK IRELAND LIMITED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 036780/0470 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2015
From: MILNER, KEITH R.
To: MEDICAL ENGINEERING AND DEVELOPMENT INSTITUTE, INC.
Reel/Frame 036780/0490 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2015
From: MEDICAL ENGINEERING AND DEVELOPMENT INSTITUTE, INC.
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 036780/0537 →